Literature DB >> 24055987

Liver masses: a clinical, radiologic, and pathologic perspective.

Sudhakar K Venkatesh1, Vishal Chandan2, Lewis R Roberts3.   

Abstract

Liver masses present a relatively common clinical dilemma, particularly with the increasing use of various imaging modalities in the diagnosis of abdominal and other symptoms. The accurate and reliable determination of the nature of the liver mass is critical, not only to reassure individuals with benign lesions but also, and perhaps more importantly, to ensure that malignant lesions are diagnosed correctly. This avoids the devastating consequences of missed diagnosis and the delayed treatment of malignancy or the unnecessary treatment of benign lesions. With appropriate interpretation of the clinical history and physical examination, and the judicious use of laboratory and imaging studies, the majority of liver masses can be characterized noninvasively. Accurate characterization of liver masses by cross-sectional imaging is particularly dependent on an understanding of the unique phasic vascular perfusion of the liver and the characteristic behaviors of different lesions during multiphasic contrast imaging. When noninvasive characterization is indeterminate, a liver biopsy may be necessary for definitive diagnosis. Standard histologic examination usually is complemented by immunohistochemical analysis of protein biomarkers. Accurate diagnosis allows the appropriate selection of optimal management, which is frequently reassurance or intermittent follow-up evaluations for benign masses. For malignant lesions or those at risk of malignant transformation, management depends on the tumor staging, the functional status of the uninvolved liver, and technical surgical considerations. Unresectable metastatic masses require oncologic consultation and therapy. The efficient characterization and management of liver masses therefore requires a multidisciplinary collaboration between the gastroenterologist/hepatologist, radiologist, pathologist, hepatobiliary or transplant surgeon, and medical oncologist.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Focal Nodular Hyperplasia; Hepatic Adenoma; Hepatic Hemangioma; Hepatocellular Carcinoma; Liver Imaging

Mesh:

Year:  2013        PMID: 24055987      PMCID: PMC3959647          DOI: 10.1016/j.cgh.2013.09.017

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  105 in total

Review 1.  The infected liver: radiologic-pathologic correlation.

Authors:  Koenraad J Mortelé; Enrica Segatto; Pablo R Ros
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

Review 2.  The varied sonographic appearances of focal fatty liver disease: review and diagnostic algorithm.

Authors:  G Bhatnagar; H S Sidhu; V Vardhanabhuti; N Venkatanarasimha; P Cantin; P Dubbins
Journal:  Clin Radiol       Date:  2012-01-20       Impact factor: 2.350

Review 3.  Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Authors:  J-L Raoul; B Sangro; A Forner; V Mazzaferro; F Piscaglia; L Bolondi; R Lencioni
Journal:  Cancer Treat Rev       Date:  2010-08-17       Impact factor: 12.111

4.  The variable CT appearance of hepatic abscesses.

Authors:  R A Halvorsen; M Korobkin; W L Foster; P M Silverman; W M Thompson
Journal:  AJR Am J Roentgenol       Date:  1984-05       Impact factor: 3.959

5.  Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Yan Shan; Yuan Ji; Cai-Zhong Chen
Journal:  J Comput Assist Tomogr       Date:  2010-07       Impact factor: 1.826

Review 6.  Imaging of HCC.

Authors:  Carmen Ayuso; Jordi Rimola; Angeles García-Criado
Journal:  Abdom Imaging       Date:  2012-04

7.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

Review 8.  Classification, diagnosis, and management of cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-13       Impact factor: 11.382

9.  MR elastography of liver tumors: preliminary results.

Authors:  Sudhakar K Venkatesh; Meng Yin; James F Glockner; Naoki Takahashi; Philip A Araoz; Jayant A Talwalkar; Richard L Ehman
Journal:  AJR Am J Roentgenol       Date:  2008-06       Impact factor: 3.959

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  19 in total

1.  Hepatic paraganglioma hiding as a slowly growing lesion for 24 years: a diagnostic conundrum.

Authors:  Caroline Annette Erika Bachmeier; Mazhar Haque; Helen L Barrett; Adam Morton
Journal:  BMJ Case Rep       Date:  2019-03-22

Review 2.  Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis.

Authors:  Khaled Y Elbanna; Ania Z Kielar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 3.  Management of hepatic adenomatosis.

Authors:  Manish Thapar; Oleg Grapp; Constantine Fisher
Journal:  Curr Gastroenterol Rep       Date:  2015-03

4.  MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings.

Authors:  Scott M Thompson; Jin Wang; Vishal S Chandan; Kevin J Glaser; Lewis R Roberts; Richard L Ehman; Sudhakar K Venkatesh
Journal:  Magn Reson Imaging       Date:  2016-11-11       Impact factor: 2.546

5.  Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.

Authors:  Zhi Qu; Qi Ling; Jill Gwiasda; Xiao Xu; Harald Schrem; Jan Beneke; Alexander Kaltenborn; Christian Krauth; Heiko Mix; Jürgen Klempnauer; Nikos Emmanouilidis
Journal:  Langenbecks Arch Surg       Date:  2018-08-17       Impact factor: 3.445

6.  Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.

Authors:  Scott M Thompson; Ishan Garg; Eric C Ehman; Shannon P Sheedy; Candice A Bookwalter; Rickey E Carter; Lewis R Roberts; Sudhakar K Venkatesh
Journal:  Br J Radiol       Date:  2018-08-29       Impact factor: 3.039

Review 7.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10

8.  Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images.

Authors:  Thodsawit Tiyarattanachai; Terapap Apiparakoon; Sanparith Marukatat; Sasima Sukcharoen; Nopavut Geratikornsupuk; Nopporn Anukulkarnkusol; Parit Mekaroonkamol; Natthaporn Tanpowpong; Pamornmas Sarakul; Rungsun Rerknimitr; Roongruedee Chaiteerakij
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

9.  Management of liver hemangioma using trans-catheter arterial embolization.

Authors:  Kavous Firouznia; Hossein Ghanaati; Seyed Moayed Alavian; Mohssen Nassiri Toosi; Nasser Ebrahimi Daryani; Amir Hossein Jalali; Madjid Shakiba; Sima Hosseinverdi
Journal:  Hepat Mon       Date:  2014-12-25       Impact factor: 0.660

10.  CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Xin Zheng; Tao Song; Changwei Dou; Yuli Jia; Qingguang Liu
Journal:  Oncotarget       Date:  2015-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.